Clinical Trials Logo

Primary Dysmenorrhea clinical trials

View clinical trials related to Primary Dysmenorrhea.

Filter by:

NCT ID: NCT06233786 Recruiting - Clinical trials for Primary Dysmenorrhea

The Effectivenes of Non-invasive Neuromodulation in Adult Women With Primary Dysmenorrhea, Through the TENS Stimulation at Different Times of Mentrual Cycle in Each Group

Dysmenorrhea
Start date: February 2024
Phase: Phase 3
Study type: Interventional

The effectiveness of non-invasive neuromodulation in adult women with primary dysmenorrhea, through the TENS stimulation at different times in each group: during the bleeding phase (G1), between days 25-28 and 1-3 of menstrual cycle, and in the luteal phase (GI2), between days 17 to 24 of menstrual cycle. The control group (CG) will be treated just like GI1, during the bleeding phase, but without the TENS transmitting the current. Participants will be evaluated by the NPRS, MPQ, SF12, CVM-22, HADS, PCS, PSQI and UDP immediately after treatment in GI1 and GC, and at the beginning of the next bleeding phase, being 28 days after the intervention in the case of GI1 and GC, and 7 days after the intervention in the case of GI2, as well as 28 days after in this last.

NCT ID: NCT06225102 Completed - Clinical trials for Primary Dysmenorrhea

The Effect of Kegel Exercise in Nursing Students With Primary Dysmenorrhoea

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

In this study, it was aimed to determine the effect of kegel exercise on menstruation symptoms, severity of dysmenorrheic symptoms and quality of life in nursing students with primary dysmenorrhea. The study was conducted as a single-blind randomized controlled trial.

NCT ID: NCT06211049 Recruiting - Clinical trials for Primary Dysmenorrhea

Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea

Start date: December 12, 2023
Phase: Phase 3
Study type: Interventional

In this Phase III study, the herbal product Vitex agnus-castus BNO 1095 20 mg will be tested. The sponsor would like to find out if treatment with Vitex agnus-castus BNO 1095 20 mg may improve the cramping pain before or during menstruation (primary dysmenorrhea) (without an organic cause) in women and if this treatment is safe. It is tested, if the pelvic pain and other symptoms during menstruation improve in patients who are treated with Vitex agnus-castus BNO 1095 20 mg and if therefore the standard treatments for primary dysmenorrhea, for example pain relief medications will not have to be increased. The study has 2 treatment groups. Patients in one group will receive Vitex agnus-castus BNO 1095 20 mg, and patients in the other group will receive a placebo. Placebo tablets look like Vitex agnus-castus BNO 1095 20 mg tablets but have no active ingredient. Patients will be randomly assigned (like tossing a coin) to one of the 2 groups (this process is called randomization). The chance for the patients to receive Vitex agnus-castus BNO 1095 is 50%. Neither the patients nor the investigators know which product the patients are taking (this method is known as "double-blind").

NCT ID: NCT06210048 Completed - Clinical trials for Primary Dysmenorrhea

Sacroiliac Joint Dysfunction and Spinal Mobility in Women With Primary Dysmenorrhoea

Start date: May 15, 2023
Phase:
Study type: Observational

Evaluation of sacroiliac joint dysfunction in young women with primary dysmenorrhoea using joint provocation and mobility tests and spinal mobility using Spinal Mouse and investigation of the relationship between primary dysmenorrhoea, sacroiliac joint dysfunction and spinal mobility.

NCT ID: NCT06200506 Active, not recruiting - Clinical trials for Primary Dysmenorrhea

Efficacy of Radiofrequency in Primary Dysmenorrhea

Rdismenorrea
Start date: January 20, 2024
Phase: N/A
Study type: Interventional

The main objective of the study is to evaluate the effect of radiofrequency on pain associated with primary dysmenorrhea. The data collected will be: Intensity of pain with the Numeric Pain Rating Scale (NPRS), pressure pain at three points of referred pain from the gynecological system, need or not to take medication, general quality of life with the SF-12 (short form 12) and quality of life in relation to menstruation with the CVM-22. They will be collected at the start of treatment, after the first post-intervention menstruation and after the second post-intervention menstruation. This study is a randomized clinical trial with two intervention groups and a control group, whose study population is women with primary dysmenorrhea. The sample size has been calculated with the G* Power 1.9.7 software using repeated measures ANOVA, assuming a two-sided significance level (α=0.05) and 90% power (β=0.10) and 10% losses. A sample of 45 participants (n) was determined to detect a significant change of 1.5 points in the variable measured with the NRS. Forty-five participants were included in this study. In the two intervention groups, radiofrequency will be applied (20 minute sessions for 3 weeks with a frequency of 3 times/week), transabdominal in one group and intravaginal in the other. Participants must be women between 18 and 35 years old, with regular menstrual cycles (22-38 days according to FIGO), be nulliparous and also not present any of the exclusion criteria detailed in the study. The data obtained will be analyzed and compared between the different groups in order to draw conclusions.

NCT ID: NCT06075654 Completed - Clinical trials for Primary Dysmenorrhea

Primary Dysmenorrhea Severity in Athletic vs. Non-Athletic Females

Start date: March 1, 2023
Phase:
Study type: Observational

The aim of the study is to investigate the difference in the severity of primary dysmenorrhea between athletic and non-athletic females.

NCT ID: NCT06057649 Not yet recruiting - Clinical trials for Primary Dysmenorrhea

Effects of Effleurage Abdominal Massage on Pain and Quality of Life in Primary Dysmenorrhea Among Students in Lahore

Start date: January 2024
Phase: N/A
Study type: Interventional

To find out the answer of the study question that effleurage abdominal massage has any effect on pain and quality of life in primary dysmenorrhea among university students or nota study will be conducted with an objective to evaluate the effects of effleurage abdominal massage on pain and quality of life in primary dysmenorrhea among university students

NCT ID: NCT06055049 Recruiting - Clinical trials for Primary Dysmenorrhea

Effects of Kinesio Tape in Primary Dysmenorrhea

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this [study type: a single-blind, placebo-controlled randomization study] was to determine the effect of kinesio taping on pain, stress, sleep, and quality of life in college students with primary dysmenorrhea. The key question(s) it aims to answer are: • [Is there a difference between pain, stress, sleep quality and quality of life scores in the post-kinesio taping intervention group and the placebo group?] Participants [both groups will come to the laboratory to replace their kinesio bands on the specified dates] If there is a comparison group: Researchers will compare with the placebo group.

NCT ID: NCT06052722 Not yet recruiting - Clinical trials for Temporomandibular Disorder

The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

Premenstrual pain, menstrual pain, other pains, and somatic symptoms may occur together. Therefore, this study aims to examine the severity of temporomandibular disorders in individuals complaining of premenstrual syndrome or dysmenorrhea and its relationship.

NCT ID: NCT06051435 Completed - Clinical trials for Primary Dysmenorrhea

Effect of Lumbar Proprioception Training on Primary Dysmenorrhea

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

the aim of this study will be to investigate the effect of lumbar proprioception training on primary dysmenorrhea.